1) tyrosine aminotransferase
酪氨酸转氨酶
1.
Lost sensibility of tyrosine aminotransferase to dexamethasone in human hepatoma cell line SMMC-7721;
地塞米松对人肝癌细胞系SMMC-7721细胞酪氨酸转氨酶活性诱导能力丧失的机制研究
2) Tyrosinase
[英]['tairəsineis,tai'rɔsi,neis] [美][taɪ'rɑsə,nes, -,nez]
酪氨酸酶
1.
Electrochemical Study of the Inhibitory Effect of Sinapic Acid and Its Derivatives on Tyrosinase Reactivity;
芥子酸及其衍生物对酪氨酸酶抑制作用的电化学研究
2.
Improvement of measurement method of tyrosinase activities in agaricus bisporus and screening of inhibitors of tyrosinase;
双孢菇酪氨酸酶测活方法的改进及其抑制剂的筛选
3.
Effect of a magnetic field on the catalytic activity of tyrosinase and its degradation of phenolic compounds;
磁场对酪氨酸酶活性及其催化降解酚类有机物影响的研究
3) tyrosine aminotransferase gene
酪氨酸转氨酶基因
4) tyrosine transaminase
酪氨酸氨基移转酶
5) Tyrosine kinase
酪氨酸激酶
1.
Effect of PDT on the activity of protein tyrosine kinase and phosphatase in H22 cells;
光动力疗法对H22细胞蛋白酪氨酸激酶及磷酸酶活性的影响
2.
Effects and mechanisms of epidermal growth factor receptor of tyrosine kinase on cancer;
表皮生长因子受体酪氨酸激酶抑制剂BPI-2009的抗肿瘤作用及其机制的研究
3.
Expression, purification and bioactivity determination of epidermal growth factor receptor protein tyrosine kinase;
表皮生长因子受体蛋白酪氨酸激酶的表达、纯化及活性测定
6) protein tyrosine kinase
酪氨酸激酶
1.
This paper reviewed recent progresses in the pharmacotherapeu- ties and clinical studies of the molecular-targeted anti-tumor drugs,including topoisomerase inhibitor, protein tyrosine kinase inhibitor,tumor angiogenesis inhibitor,PI3K-AKT-mTOR inhibitor and cyclin-de- pendent kinase inhib.
笔者综述了近年来DNA拓扑异构酶抑制剂、蛋白酪氨酸激酶抑制剂、肿瘤新生血管生成抑制剂、磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶体(PI3K-AKT-mTOR)信号通路抑制剂、细胞周期依赖性蛋白激酶抑制剂的临床应用和临床研究进展。
补充资料：谷氨酸丙酮酸转氨酶
谷氨酸丙酮酸转氨酶
见"血清转氨酶"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条